Table 1.
The effects of antiviral agents and resistance inducers on the incidence of tobacco mosaic disease
| Treatment | Antiviral agents at 1 day after infection | Antiviral agents at 3 days after infection | Resistance inducers | ||||||
|---|---|---|---|---|---|---|---|---|---|
| CK | AO | GC | CK | AO | GC | CK | MH | MG | |
| Incidence (%) | 93.50 ± 4.03 | 23.30 ± 1.15 | 33.30 ± 1.56 | 96.70 ± 4.26 | 83.45 ± 4.03 | 76.67 ± 4.07 | 93.50 ± 4.03 | 36.70 ± 1.52 | 30.00 ± 1.09 |
The incidences of tobacco mosaic disease were surveyed at 7 days after infection. The resistance inducers were used at 7 days before infection
CK (control) infection of TMV, AO spraying with amino-oligosaccharin after infection, GC spraying with guanidine-copper acetate after infection, MH spraying with moroxydine hydrochloride, MG spraying with N-glycoside morpholine guanidine